,
your personalized virtual assistant to find clinical trials. Go head, 
Donna White
MetroHealth Medical CenterCleveland, Ohio - 44109 (216-778-2223) |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS2
- SINCE2009
Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
March 2009 - September 2012
Ovarian Neoplasms
Recurrence
Morab-003 (Farletuzumab)
0.9% Saline
